Afuco™ Anti-NT5E ADCC Therapeutic Antibody (Oleclumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to NT5E. Oleclumab is a human monoclonal antibody that can be potentially used in the treatment of Solid Tumours, Pancreatic and Colorectal cancer.
Supplier Creative Biolabs
Product # AFC-TAB-441CQ
Pricing Inquiry
Host Human
Target NT5E
Species Reactivity Human
Type ADCC enhanced antibody
Applications ELISA, IHC, FC, IP, IF, FuncS
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback